Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders. Behavioural and Psychophisiological Measures

NCT06874166 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT06874166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06874166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders. Behavioural and Psychophisiological Measures
Lead sponsor
IRCCS Eugenio Medea
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
December 31, 2027
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne / becker muscular dystrophy, osteogenesis imperfecta (oi), social cognition